iX Biopharma Ltd. 42C
SGX · Singapore · Health Technology
SGD 0.5500+0.02 (+2.80%)
Market closed· · SGD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SGD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Key Insights iX Biopharma's significant insider ownership suggests inherent interests in company's expansion 51% of the...
While stock picking isn't easy, for those willing to persist and learn, it is possible to buy shares in great...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.